Telomere aberrations, including telomere loss, doublets, and extreme shortening, are increased in patients with infertility.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
01 2021
Historique:
received: 11 03 2020
revised: 02 07 2020
accepted: 06 07 2020
pubmed: 5 12 2020
medline: 22 6 2021
entrez: 4 12 2020
Statut: ppublish

Résumé

To test the hypothesis that telomere shortening and/or loss are risk factors for infertility. Retrospective analysis of the telomere status in patients with infertility using conventional cytogenetic data collected prospectively. Academic centers. Cytogenetic slides with cultured peripheral lymphocytes from 50 patients undergoing fertility treatment and 150 healthy donors, including 100 donors matched for age. Cytogenetic slides were used to detect chromosomal and telomere aberrations. Telomere length and telomere aberrations were analyzed after telomere and centromere staining. The mean telomere length of patients consulting for infertility was significantly less than that of healthy donors of similar age. Moreover, patients with infertility showed significantly more extreme telomere loss and telomere doublet formation than healthy controls. Telomere shortening and/or telomere aberrations were more pronounced in patients with structural chromosomal aberrations. Dicentric chromosomes were identified in 6/13 patients, with constitutional chromosomal aberrations leading to chromosomal instability that correlated with chromosomal end-to-end fusions. Our findings demonstrate the feasibility of analyzing telomere aberrations in addition to chromosomal aberrations, using cytogenetic slides. Telomere attrition and/or dysfunction represent the main common cytogenetic characteristic of patients with infertility, leading to potential implications for fertility assessment. Pending further studies, these techniques that correlate the outcome of assisted reproduction and telomere integrity status may represent a novel and useful diagnostic and/or prognostic tool for medical care in this field.

Identifiants

pubmed: 33272625
pii: S0015-0282(20)30629-4
doi: 10.1016/j.fertnstert.2020.07.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-173

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Radhia M'kacher (R)

Cell Environment, DNA Damage Research & Development, Paris, France. Electronic address: radhia.mkacher@cell-environment.com.

Bruno Colicchio (B)

Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, Mulhouse, France.

Valentine Marquet (V)

Service de Cytogénétique, Génétique Médicale, et Biologie de la Reproduction Hôpital de la Mère et de l'Enfant, Centre hospitalo-universitaire Dupuytren, Limoges, France.

Claire Borie (C)

Assitance Pubique-Hopitaux de Paris (APHP)-Service d'hématologie-Oncohématologie Moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/INSERM 935, Villejuif, France.

Wala Najar (W)

Cell Environment, DNA Damage Research & Development, Paris, France; Faculté de médecine Paris Centre, Université de Paris, Paris, France.

William M Hempel (WM)

Cell Environment, DNA Damage Research & Development, Paris, France.

Leonhard Heidingsfelder (L)

MetaSystems GmbH, Altlussheim, Germany.

Noufissa Oudrhiri (N)

Assitance Pubique-Hopitaux de Paris (APHP)-Service d'hématologie-Oncohématologie Moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/INSERM 935, Villejuif, France.

Mustafa Al Jawhari (M)

Cell Environment, DNA Damage Research & Development, Paris, France.

Nadège Wilhelm-Murer (N)

Service de génétique Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse, France.

Marguerite Miguet (M)

Service de génétique Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse, France.

Alain Dieterlen (A)

Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, Mulhouse, France.

Georges Deschênes (G)

Nephrology Department, APHP-Hopital Robert Debré, Paris, France.

Anne-Claude Tabet (AC)

Cytogenetic Laboratory, APHP-Hopital Robert Debré, Paris, France.

Steffen Junker (S)

Institute of Biomedicine, University of Aarhus, Aarhus, Denmark.

Michael Grynberg (M)

Department of Reproductive Medicine and Fertility Preservation, Hôpital Antoine Béclère, Clamart, France.

Michael Fenech (M)

School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia; Genome Health Foundation, North Brighton, South Australia, Australia.

Annelise Bennaceur-Griscelli (A)

Assitance Pubique-Hopitaux de Paris (APHP)-Service d'hématologie-Oncohématologie Moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/INSERM 935, Villejuif, France.

Philippe Voisin (P)

Cell Environment, DNA Damage Research & Development, Paris, France.

Patrice Carde (P)

Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France.

Eric Jeandidier (E)

Service de génétique Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse, France.

Catherine Yardin (C)

Service de Cytogénétique, Génétique Médicale, et Biologie de la Reproduction Hôpital de la Mère et de l'Enfant, Centre hospitalo-universitaire Dupuytren, Limoges, France; CNRS, XLIM, UMR 7252, University of Limoges, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH